Molecular subtyping and insights into sarcoma biology and prognosis. Log10 change in ctDNA from baseline at end of cycle 1 and cycle 2 chemotherapy by initial imaging response. Initial Response Cycle ...
Comprehensive Clinical and Molecular Characterization of KRASG12C-Mutant Colorectal Cancer Tumor burden staying below the baseline burden throughout therapy, noted in 55 patients (63%), was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results